CAS: 1227948-02-8
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
BI-4464 REF: AN-AG01MVJRCAS: 1227948-02-8 | 98% | 169.00 €~1,951.00 € | Mon 06 May 24 | |
BI-4464 REF: TM-T5480CAS: 1227948-02-8 | 98% | 65.00 €~797.00 € | Mon 13 May 24 | |
BI-4464 REF: 3D-CZB94802CAS: 1227948-02-8 | Min. 95% | To inquire | Mon 17 Jun 24 |
Ref: AN-AG01MVJR
1g | 1,951.00 € | |
25mg | 169.00 € | |
50mg | 268.00 € | |
100mg | 570.00 € | |
250mg | 685.00 € |
Estimated delivery in United States, on Monday 6 May 2024
BI-4464
CAS:1227948-02-8
BI-4464 is a highly selective ATP competitive inhibitor of PTK2/FAK, with an IC50 of 17 …
Formula:
C28H28F3N5O4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
555.55
- Inhibitors
- Angiogenesis
- FAK
- Tyrosine Kinase/Adaptors
- See more categories
- Cytoskeletal Signaling
Ref: TM-T5480
1mg | 65.00 € | |
2mg | 92.00 € | |
5mg | 142.00 € | |
10mg | 222.00 € | |
25mg | 369.00 € | |
50mg | 547.00 € | |
100mg | 797.00 € |
Estimated delivery in United States, on Monday 13 May 2024
BI-4464
CAS:1227948-02-8
BI-4464 is a novel anti-inflammatory agent that has been shown to have a potential beneficial …
Formula:
C28H28F3N5O4
Purity:
Min. 95%
Molecular weight:
555.55 g/mol
Ref: 3D-CZB94802
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Monday 17 Jun 2024